H.R. 4718 · 109th Congress
Drug Company Gift Disclosure Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 109th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
DeFazioSponsorNo cosponsors.
Drug Company Gift Disclosure Act - Amends the Federal Food, Drug, and Cosmetic Act to require prescription drug manufacturers, packers, and distributors to annually disclose to the Commissioner of Food and Drugs the value, nature, and purpose of: (1) gifts made in connection with detailing, promotion, or other marketing activity to any physician, hospital,…
What it does: CRS summary · Introduced in House · Feb 8, 2006
Drug Company Gift Disclosure Act - Amends the Federal Food, Drug, and Cosmetic Act to require prescription drug manufacturers, packers, and distributors to annually disclose to the Commissioner of Food and Drugs the value, nature, and purpose of: (1) gifts made in connection with detailing, promotion, or other marketing activity to any physician, hospital, nursing home, pharmacist, health benefit plan administrator, or any other person authorized to prescribe or dispense prescription drugs; and (2) cash rebates, discounts, or any other financial consideration given to any pharmaceutical benefit manager in connection with such marketing activities. Defines "gift" as any gift, fee, payment, subsidy, or other economic benefit with a value of $50 or more, except free samples of prescription drugs and the payment of reasonable compensation and reimbursement of expenses in connection with a bona fide clinical trial.
Requires the Commissioner to: (1) make such information available to the public; and (2) keep confidential any information related to a trade secret. Establishes civil penalties for violations.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Drug Company Gift Disclosure Act
Latest action (Feb 17, 2006): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Feb 8, 2006
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.